2024 Recipients of NMD4C and MDC Neuromuscular Fellowship Funding Competition
Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2024 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in NMD research and clinical fellowships in neuromuscular medicine and electromyography! NMD4C and MDC are committed to empowering the next generation of early-career researchers and clinicians in building successful careers in neuromuscular disease (NMD) research and clinical practice to improve neuromuscular care, research, treatment, and health outcomes for all Canadians.
The 2024 competition provides salary support for two early-career scientists to conduct postdoctoral studies in laboratories focused on NMD research, and three early-career neurologists to participate in neuromuscular medicine and electromyography training programs. Successful applicants receive $40 000 in funding over a one-year period for postdoctoral fellowships, and $80 000 in funding over a one-year period for clinical fellowships. Since 2022, this competition has provided $1 million in funding to support neuromuscular postdoctoral researchers and clinical fellows in Canada, made possible by generous supporters of MDC, with one clinical fellow each year by the Canadian Society for Clinical Neurophysiologists.
This competition involves an extensive review by leading Canadian neuromuscular researchers and clinicians to ensure the top-ranked candidates are selected for this funding opportunity. From the entire neuromuscular community, congratulations to all 2024 recipients!
Postdoctoral Fellowship Recipients:
Dr. Yassine Ouhaddi Centre de recherche du CHU Sainte-Justine, Montreal, QC
Learn more about the 2024 postdoctoral fellows and their research projects.
Clinical Fellowship Recipients
Dr. Yiu-Chia Chang University of Western Ontario, London, ON
Dr. Mark Krongold University of British Columbia, Vancouver, BC
Dr. Bram De Wel University of Calgary, Calgary, AB
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.